 Connection
Eric Simoes to Infant, Premature
This is a "connection" page, showing publications Eric Simoes has written about Infant, Premature.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.487 |
|
|
|
-
Simoes EA, Groothuis JR, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick LM, Kimpen JL. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr. 2007 Jul; 151(1):34-42, 42.e1.
Score: 0.197
-
Simoes EA, Rosenberg AA, King SJ, Groothuis JR. Room air challenge: prediction for successful weaning of oxygen-dependent infants. J Perinatol. 1997 Mar-Apr; 17(2):125-9.
Score: 0.096
-
Simoes EA, King SJ, Lehr MV, Groothuis JR. Preterm twins and triplets. A high-risk group for severe respiratory syncytial virus infection. Am J Dis Child. 1993 Mar; 147(3):303-6.
Score: 0.073
-
Leidy NK, Margolis MK, Marcin JP, Flynn JA, Frankel LR, Johnson S, Langkamp D, Simoes EA. The impact of severe respiratory syncytial virus on the child, caregiver, and family during hospitalization and recovery. Pediatrics. 2005 Jun; 115(6):1536-46.
Score: 0.043
-
Law BJ, Carbonell-Estrany X, Simoes EA. An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir Med. 2002 Apr; 96 Suppl B:S1-7.
Score: 0.034
-
Simoes EA, Groothuis JR, Tristram DA, Allessi K, Lehr MV, Siber GR, Welliver RC. Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children. J Pediatr. 1996 Aug; 129(2):214-9.
Score: 0.023
-
Rodriguez WJ, Gruber WC, Welliver RC, Groothuis JR, Simoes EA, Meissner HC, Hemming VG, Hall CB, Lepow ML, Rosas AJ, Robertsen C, Kramer AA. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics. 1997 Mar; 99(3):454-61.
Score: 0.006
-
Groothuis JR, Simoes EA, Hemming VG. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics. 1995 Apr; 95(4):463-7.
Score: 0.005
-
Groothuis JR, Simoes EA, Lehr MV, Kramer AA, Hemming VG, Rodriguez WJ, Arrobio J, Welliver RC, Siber GR. Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulin. Antimicrob Agents Chemother. 1995 Mar; 39(3):668-71.
Score: 0.005
-
Groothuis JR, Simoes EA, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med. 1993 Nov 18; 329(21):1524-30.
Score: 0.005
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|